Table of Contents

1 Study Coverage

• 1.1 Medical Probiotics Product
• 1.2 Market Segments
• 1.3 Key Manufacturers Covered
• 1.4 Market by Type
  • 1.4.1 Global Medical Probiotics Market Size Growth Rate by Product
  • 1.4.2 Bifidobacterium
  • 1.4.3 Lactobacillus
  • 1.4.4 Others
• 1.5 Market by End User
  • 1.5.1 Global Medical Probiotics Market Size Growth Rate by End User
  • 1.5.2 Pharmaceuticals
  • 1.5.3 Dietary Supplements
  • 1.5.4 Others
• 1.6 Study Objectives
• 1.7 Years Considered

2 Executive Summary

• 2.1 Global Medical Probiotics Market Size
  • 2.1.1 Global Medical Probiotics Revenue 2014-2025
  • 2.1.2 Global Medical Probiotics Sales 2014-2025
• 2.2 Medical Probiotics Growth Rate by Regions
  • 2.2.1 Global Medical Probiotics Sales by Regions
  • 2.2.2 Global Medical Probiotics Revenue by Regions

3 Breakdown Data by Manufacturers

• 3.1 Medical Probiotics Sales by Manufacturers
  • 3.1.1 Medical Probiotics Sales by Manufacturers
  • 3.1.2 Medical Probiotics Sales Market Share by Manufacturers
  • 3.1.3 Global Medical Probiotics Market Concentration Ratio (CR5 and HHI)
• 3.2 Medical Probiotics Revenue by Manufacturers
  • 3.2.1 Medical Probiotics Revenue by Manufacturers (2014-2019)
  • 3.2.2 Medical Probiotics Revenue Share by Manufacturers (2014-2019)
• 3.3 Medical Probiotics Price by Manufacturers
• 3.4 Medical Probiotics Manufacturing Base Distribution, Product Types
  • 3.4.1 Medical Probiotics Manufacturers Manufacturing Base Distribution, Headquarters
  • 3.4.2 Manufacturers Medical Probiotics Product Type
  • 3.4.3 Date of International Manufacturers Enter into Medical Probiotics Market
• 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Product

• 4.1 Global Medical Probiotics Sales by Product
• 4.2 Global Medical Probiotics Revenue by Product
• 4.3 Medical Probiotics Price by Product

5 Breakdown Data by End User

• 5.1 Overview
• 5.2 Global Medical Probiotics Breakdown Data by End User

6 North America

• 6.1 North America Medical Probiotics by Countries
  • 6.1.1 North America Medical Probiotics Sales by Countries
  • 6.1.2 North America Medical Probiotics Revenue by Countries
  • 6.1.3 United States
  • 6.1.4 Canada
  • 6.1.5 Mexico
• 6.2 North America Medical Probiotics by Product
• 6.3 North America Medical Probiotics by End User

7 Europe

• 7.1 Europe Medical Probiotics by Countries
  • 7.1.1 Europe Medical Probiotics Sales by Countries
  • 7.1.2 Europe Medical Probiotics Revenue by Countries
  • 7.1.3 Germany
  • 7.1.4 France
  • 7.1.5 UK
  • 7.1.6 Italy
  • 7.1.7 Russia
• 7.2 Europe Medical Probiotics by Product
• 7.3 Europe Medical Probiotics by End User

8 Asia Pacific

• 8.1 Asia Pacific Medical Probiotics by Countries
  • 8.1.1 Asia Pacific Medical Probiotics Sales by Countries
  • 8.1.2 Asia Pacific Medical Probiotics Revenue by Countries
  • 8.1.3 China
  • 8.1.4 Japan
  • 8.1.5 Korea
  • 8.1.6 India
  • 8.1.7 Australia
  • 8.1.8 Indonesia
  • 8.1.9 Malaysia
  • 8.1.10 Philippines
  • 8.1.11 Thailand
  • 8.1.12 Vietnam
  • 8.1.13 Singapore
• 8.2 Asia Pacific Medical Probiotics by Product
• 8.3 Asia Pacific Medical Probiotics by End User

9 Central & South America

• 9.1 Central & South America Medical Probiotics by Countries
  • 9.1.1 Central & South America Medical Probiotics Sales by Countries
  • 9.1.2 Central & South America Medical Probiotics Revenue by Countries
  • 9.1.3 Brazil
• 9.2 Central & South America Medical Probiotics by Product
• 9.3 Central & South America Medical Probiotics by End User

10 Middle East and Africa

• 10.1 Middle East and Africa Medical Probiotics by Countries
  • 10.1.1 Middle East and Africa Medical Probiotics Sales by Countries
  • 10.1.2 Middle East and Africa Medical Probiotics Revenue by Countries
  • 10.1.3 GCC Countries
  • 10.1.4 Turkey
  • 10.1.5 Egypt
  • 10.1.6 South Africa
• 10.2 Middle East and Africa Medical Probiotics by Product
• 10.3 Middle East and Africa Medical Probiotics by End User

11 Company Profiles

• 11.1 DowDuPont (Danisco)
  • 11.1.1 DowDuPont (Danisco) Company Details
  • 11.1.2 Company Business Overview
  • 11.1.3 DowDuPont (Danisco) Medical Probiotics Sales, Revenue and Gross Margin (2014-2019)
  • 11.1.4 DowDuPont (Danisco) Medical Probiotics Products Offered
  • 11.1.5 DowDuPont (Danisco) Recent Development
• 11.2 Chr. Hansen
  • 11.2.1 Chr. Hansen Company Details
  • 11.2.2 Company Business Overview
  • 11.2.3 Chr. Hansen Medical Probiotics Sales, Revenue and Gross Margin (2014-2019)
  • 11.2.4 Chr. Hansen Medical Probiotics Products Offered
  • 11.2.5 Chr. Hansen Recent Development
• 11.3 Lallemand
  • 11.3.1 Lallemand Company Details
  • 11.3.2 Company Business Overview
  • 11.3.3 Lallemand Medical Probiotics Sales, Revenue and Gross Margin (2014-2019)
  • 11.3.4 Lallemand Medical Probiotics Products Offered
  • 11.3.5 Lallemand Recent Development
• 11.4 China-Biotics
  • 11.4.1 China-Biotics Company Details
  • 11.4.2 Company Business Overview
  • 11.4.3 China-Biotics Medical Probiotics Sales, Revenue and Gross Margin (2014-2019)
  • 11.4.4 China-Biotics Medical Probiotics Products Offered
  • 11.4.5 China-Biotics Recent Development
• 11.5 Nestle
  • 11.5.1 Nestle Company Details
  • 11.5.2 Company Business Overview
  • 11.5.3 Nestle Medical Probiotics Sales, Revenue and Gross Margin (2014-2019)
  • 11.5.4 Nestle Medical Probiotics Products Offered
  • 11.5.5 Nestle Recent Development
• 11.6 Danone
  • 11.6.1 Danone Company Details
  • 11.6.2 Company Business Overview
  • 11.6.3 Danone Medical Probiotics Sales, Revenue and Gross Margin (2014-2019)
  • 11.6.4 Danone Medical Probiotics Products Offered
  • 11.6.5 Danone Recent Development
• 11.7 Probi
  • 11.7.1 Probi Company Details
  • 11.7.2 Company Business Overview
  • 11.7.3 Probi Medical Probiotics Sales, Revenue and Gross Margin (2014-2019)
  • 11.7.4 Probi Medical Probiotics Products Offered
  • 11.7.5 Probi Recent Development
• 11.8 BioGaia
  • 11.8.1 BioGaia Company Details
  • 11.8.2 Company Business Overview
  • 11.8.3 BioGaia Medical Probiotics Sales, Revenue and Gross Margin (2014-2019)
  • 11.8.4 BioGaia Medical Probiotics Products Offered
  • 11.8.5 BioGaia Recent Development
• 11.9 Novozymes
  • 11.9.1 Novozymes Company Details
  • 11.9.2 Company Business Overview
  • 11.9.3 Novozymes Medical Probiotics Sales, Revenue and Gross Margin (2014-2019)
  • 11.9.4 Novozymes Medical Probiotics Products Offered
  • 11.9.5 Novozymes Recent Development
• 11.10 DSM
  • 11.10.1 DSM Company Details
  • 11.10.2 Company Business Overview
  • 11.10.3 DSM Medical Probiotics Sales, Revenue and Gross Margin (2014-2019)
  • 11.10.4 DSM Medical Probiotics Products Offered
  • 11.10.5 DSM Recent Development
• 11.11 Ganeden
• 11.12 Glory Biotech
• 11.13 Unique Biotech
• 11.14 Winclove Probiotics
• 11.15 UAS Laboratories
• 11.16 Synbiotech

12 Future Forecast

• 12.1 Medical Probiotics Market Forecast by Regions
  • 12.1.1 Global Medical Probiotics Sales Forecast by Regions 2019-2025
  • 12.1.2 Global Medical Probiotics Revenue Forecast by Regions 2019-2025
• 12.2 Medical Probiotics Market Forecast by Product
  • 12.2.1 Global Medical Probiotics Sales Forecast by Product 2019-2025
  • 12.2.2 Global Medical Probiotics Revenue Forecast by Product 2019-2025
• 12.3 Medical Probiotics Market Forecast by End User
• 12.4 North America Medical Probiotics Forecast
• 12.5 Europe Medical Probiotics Forecast
• 12.6 Asia Pacific Medical Probiotics Forecast
• 12.7 Central & South America Medical Probiotics Forecast
• 12.8 Middle East and Africa Medical Probiotics Forecast

13 Market Opportunities, Challenges, Risks and Influences Factors Analysis

• 13.1 Market Opportunities and Drivers
• 13.2 Market Challenges
• 13.3 Market Risks/Restraints
• 13.4 Macroscopic Indicators

14 Value Chain and Sales Channels Analysis

• 14.1 Value Chain Analysis
• 14.2 Medical Probiotics Customers
• 14.3 Sales Channels Analysis
  • 14.3.1 Sales Channels
  • 14.3.2 Distributors

15 Research Findings and Conclusion

16 Appendix

• 16.1 Research Methodology
  • 16.1.1 Methodology/Research Approach
  • 16.1.2 Data Source
• 16.2 Author Details

Medical probiotics are live micro-organisms which, when administrated in adequate amounts, confer a health benefit on the host. While the traditional delivery vehicle for probiotics was fresh dairy products, they are now found in many varieties of dietary supplements and healthcare products.
The global Medical Probiotics market is valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025. The objectives of this study are to define, segment, and project the size of the Medical Probiotics market based on company, product type, end user and key regions.

This report studies the global market size of Medical Probiotics in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Medical Probiotics in these regions.
This research report categorizes the global Medical Probiotics market by top players/brands, region, type and end user. This report also studies the global Medical Probiotics market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.

The following manufacturers are covered in this report, with sales, revenue, market share for each company:
DowDuPont (Danisco)
Chr. Hansen
Lallemand
China-Biotics
Nestle
Danone
Probi
BioGaia
Novozymes
DSM
Ganeden
Glory Biotech
Unique Biotech
Winclove Probiotics
UAS Laboratories
Synbiotech

Market size by Product
Bifidobacterium
Lactobacillus
Others
Market size by End User
Pharmaceuticals
Dietary Supplements
Others

Market size by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Malaysia
Philippines
Thailand
Vietnam
Europe
Germany
France
UK
Italy
Spain
Russia
Central & South America
Brazil
Rest of Central & South America
Middle East & Africa
GCC Countries
Turkey
Egypt
South Africa

The study objectives of this report are:
To study and analyze the global Medical Probiotics market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.
To understand the structure of Medical Probiotics market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
Focuses on the key global Medical Probiotics companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
To project the value and sales volume of Medical Probiotics submarkets, with respect to key regions.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

In this study, the years considered to estimate the market size of Medical Probiotics are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025

This report includes the estimation of market size for value (million US$) and volume (K MT). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Medical Probiotics market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.

For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.